Kracov Quoted in Bloomberg BNA on FDA's Potential Expansion of Generic Drug Access

Life Sciences and Healthcare Regulatory co-chair and partner Dan Kracov was quoted in a recent Bloomberg BNA article, "Grassley, FDA Focus on Increasing Generic Drug Competition," which discusses the pricing practices and rules governing entry to the generic drug market used by drugmakers.

» Read the full article (subscription required).